Genes involved in neurodevelopment, neuroplasticity and major depression: No association for CACNA1C, CHRNA7 and MAPK1

Marco Calabrò, Laura Mandelli, Concetta Crisafulli, Soo Jung Lee, Tae Youn Jun, Sheng Min Wang, Ashwin A. Patkar, Prakash S. Masand, Changsu Han, Chi Un Pae, Alessandro Serretti

Research output: Contribution to journalArticle

Abstract

Objective: Genetics factors are likely to play a role in the risk, clinical presentation and treatment outcome in major depressive disorder (MDD). In this study, we investigated the role of three candidate genes for MDD; calcium voltagegated channel subunit alpha1 C (CACNA1C ), cholinergic receptor nicotinic alpha 7 subunit (CHRNA7 ), and mitogenactivated protein kinase 1 (MAPK1 ). Methods: Two-hundred forty-two MDD patients and 326 healthy controls of Korean ancestry served as samples for the analyses. Thirty-nine single nucleotide polymorphisms (SNPs) within CACNA1C, CHRNA7, and MAPK1 genes were genotyped and subsequently tested for association with MDD (primary analysis) and other clinical features (symptoms' severity, age of onset, history of suicide attempt, treatment outcome) (secondary analyses). Single SNPs, haplotypes and epistatic analyses were performed. Results: Single SNPs were not associated with disease risk and clinical features. However, a combination of alleles (haplotype) within MAPK1 was found associated with MDD-status. Secondary analyses detected a possible involvement of CACNA1C haplotype in resistance to antidepressant treatment. Conclusion: These data suggest a role for MAPK1 and CACNA1C in MDD risk and treatment resistance, respectively. However, since many limitations characterize the analysis, the results must be considered with great caution and verified.

Original languageEnglish
Pages (from-to)364-368
Number of pages5
JournalClinical Psychopharmacology and Neuroscience
Volume17
Issue number3
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

Neuronal Plasticity
Major Depressive Disorder
Calcium Channels
Protein Kinases
Depression
Haplotypes
Genes
Single Nucleotide Polymorphism
Age of Onset
Suicide
Antidepressive Agents
Mouse Chrna7 protein
Alleles
Therapeutics

Keywords

  • CACNA1C
  • CHRNA7
  • Deep phenotyping
  • Major depressive disorder
  • MAPK1

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Pharmacology (medical)

Cite this

Genes involved in neurodevelopment, neuroplasticity and major depression : No association for CACNA1C, CHRNA7 and MAPK1. / Calabrò, Marco; Mandelli, Laura; Crisafulli, Concetta; Lee, Soo Jung; Jun, Tae Youn; Wang, Sheng Min; Patkar, Ashwin A.; Masand, Prakash S.; Han, Changsu; Pae, Chi Un; Serretti, Alessandro.

In: Clinical Psychopharmacology and Neuroscience, Vol. 17, No. 3, 01.01.2019, p. 364-368.

Research output: Contribution to journalArticle

Calabrò, M, Mandelli, L, Crisafulli, C, Lee, SJ, Jun, TY, Wang, SM, Patkar, AA, Masand, PS, Han, C, Pae, CU & Serretti, A 2019, 'Genes involved in neurodevelopment, neuroplasticity and major depression: No association for CACNA1C, CHRNA7 and MAPK1', Clinical Psychopharmacology and Neuroscience, vol. 17, no. 3, pp. 364-368. https://doi.org/10.9758/cpn.2019.17.3.364
Calabrò, Marco ; Mandelli, Laura ; Crisafulli, Concetta ; Lee, Soo Jung ; Jun, Tae Youn ; Wang, Sheng Min ; Patkar, Ashwin A. ; Masand, Prakash S. ; Han, Changsu ; Pae, Chi Un ; Serretti, Alessandro. / Genes involved in neurodevelopment, neuroplasticity and major depression : No association for CACNA1C, CHRNA7 and MAPK1. In: Clinical Psychopharmacology and Neuroscience. 2019 ; Vol. 17, No. 3. pp. 364-368.
@article{585a9d69f6db4336bc4b099cab8b8e21,
title = "Genes involved in neurodevelopment, neuroplasticity and major depression: No association for CACNA1C, CHRNA7 and MAPK1",
abstract = "Objective: Genetics factors are likely to play a role in the risk, clinical presentation and treatment outcome in major depressive disorder (MDD). In this study, we investigated the role of three candidate genes for MDD; calcium voltagegated channel subunit alpha1 C (CACNA1C ), cholinergic receptor nicotinic alpha 7 subunit (CHRNA7 ), and mitogenactivated protein kinase 1 (MAPK1 ). Methods: Two-hundred forty-two MDD patients and 326 healthy controls of Korean ancestry served as samples for the analyses. Thirty-nine single nucleotide polymorphisms (SNPs) within CACNA1C, CHRNA7, and MAPK1 genes were genotyped and subsequently tested for association with MDD (primary analysis) and other clinical features (symptoms' severity, age of onset, history of suicide attempt, treatment outcome) (secondary analyses). Single SNPs, haplotypes and epistatic analyses were performed. Results: Single SNPs were not associated with disease risk and clinical features. However, a combination of alleles (haplotype) within MAPK1 was found associated with MDD-status. Secondary analyses detected a possible involvement of CACNA1C haplotype in resistance to antidepressant treatment. Conclusion: These data suggest a role for MAPK1 and CACNA1C in MDD risk and treatment resistance, respectively. However, since many limitations characterize the analysis, the results must be considered with great caution and verified.",
keywords = "CACNA1C, CHRNA7, Deep phenotyping, Major depressive disorder, MAPK1",
author = "Marco Calabr{\`o} and Laura Mandelli and Concetta Crisafulli and Lee, {Soo Jung} and Jun, {Tae Youn} and Wang, {Sheng Min} and Patkar, {Ashwin A.} and Masand, {Prakash S.} and Changsu Han and Pae, {Chi Un} and Alessandro Serretti",
year = "2019",
month = "1",
day = "1",
doi = "10.9758/cpn.2019.17.3.364",
language = "English",
volume = "17",
pages = "364--368",
journal = "Clinical Psychopharmacology and Neuroscience",
issn = "1738-1088",
publisher = "Korean College of Neuropsychopharmacology",
number = "3",

}

TY - JOUR

T1 - Genes involved in neurodevelopment, neuroplasticity and major depression

T2 - No association for CACNA1C, CHRNA7 and MAPK1

AU - Calabrò, Marco

AU - Mandelli, Laura

AU - Crisafulli, Concetta

AU - Lee, Soo Jung

AU - Jun, Tae Youn

AU - Wang, Sheng Min

AU - Patkar, Ashwin A.

AU - Masand, Prakash S.

AU - Han, Changsu

AU - Pae, Chi Un

AU - Serretti, Alessandro

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: Genetics factors are likely to play a role in the risk, clinical presentation and treatment outcome in major depressive disorder (MDD). In this study, we investigated the role of three candidate genes for MDD; calcium voltagegated channel subunit alpha1 C (CACNA1C ), cholinergic receptor nicotinic alpha 7 subunit (CHRNA7 ), and mitogenactivated protein kinase 1 (MAPK1 ). Methods: Two-hundred forty-two MDD patients and 326 healthy controls of Korean ancestry served as samples for the analyses. Thirty-nine single nucleotide polymorphisms (SNPs) within CACNA1C, CHRNA7, and MAPK1 genes were genotyped and subsequently tested for association with MDD (primary analysis) and other clinical features (symptoms' severity, age of onset, history of suicide attempt, treatment outcome) (secondary analyses). Single SNPs, haplotypes and epistatic analyses were performed. Results: Single SNPs were not associated with disease risk and clinical features. However, a combination of alleles (haplotype) within MAPK1 was found associated with MDD-status. Secondary analyses detected a possible involvement of CACNA1C haplotype in resistance to antidepressant treatment. Conclusion: These data suggest a role for MAPK1 and CACNA1C in MDD risk and treatment resistance, respectively. However, since many limitations characterize the analysis, the results must be considered with great caution and verified.

AB - Objective: Genetics factors are likely to play a role in the risk, clinical presentation and treatment outcome in major depressive disorder (MDD). In this study, we investigated the role of three candidate genes for MDD; calcium voltagegated channel subunit alpha1 C (CACNA1C ), cholinergic receptor nicotinic alpha 7 subunit (CHRNA7 ), and mitogenactivated protein kinase 1 (MAPK1 ). Methods: Two-hundred forty-two MDD patients and 326 healthy controls of Korean ancestry served as samples for the analyses. Thirty-nine single nucleotide polymorphisms (SNPs) within CACNA1C, CHRNA7, and MAPK1 genes were genotyped and subsequently tested for association with MDD (primary analysis) and other clinical features (symptoms' severity, age of onset, history of suicide attempt, treatment outcome) (secondary analyses). Single SNPs, haplotypes and epistatic analyses were performed. Results: Single SNPs were not associated with disease risk and clinical features. However, a combination of alleles (haplotype) within MAPK1 was found associated with MDD-status. Secondary analyses detected a possible involvement of CACNA1C haplotype in resistance to antidepressant treatment. Conclusion: These data suggest a role for MAPK1 and CACNA1C in MDD risk and treatment resistance, respectively. However, since many limitations characterize the analysis, the results must be considered with great caution and verified.

KW - CACNA1C

KW - CHRNA7

KW - Deep phenotyping

KW - Major depressive disorder

KW - MAPK1

UR - http://www.scopus.com/inward/record.url?scp=85072164170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072164170&partnerID=8YFLogxK

U2 - 10.9758/cpn.2019.17.3.364

DO - 10.9758/cpn.2019.17.3.364

M3 - Article

AN - SCOPUS:85072164170

VL - 17

SP - 364

EP - 368

JO - Clinical Psychopharmacology and Neuroscience

JF - Clinical Psychopharmacology and Neuroscience

SN - 1738-1088

IS - 3

ER -